SC 13G: OnKure Therapeutics, Inc.

AI Summary

SC 13G filing by OnKure Therapeutics, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — suer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d863547dsc13g.htm (SC 13G) — 70KB
• d863547dex991.htm (EX-99.1) — 5KB
• 0001193125-24-235212.txt ( ) — 77KB

From the Filing

SC 13G 1 d863547dsc13g.htm SC 13G SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* ONKURE THERAPEUTICS, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 68277Q105 (CUSIP Number) October 4, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1. NAMES OF REPORTING PERSONS Acorn Bioventures, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 1,439,674 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 1,439,674 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,439,674 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11.4% 12. TYPE OF REPORTING PERSON PN 1. NAMES OF REPORTING PERSONS Acorn Capital Advisors GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 1,439,674 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 1,439,674 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,439,674 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11.4% 12. TYPE OF REPORTING PERSON OO 1. NAMES OF REPORTING PERSONS Anders Hove 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 1,439,674 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 1,439,674 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,439,674 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11.4% 12. TYPE OF REPORTING PERSON IN Item1. Issuer (a) Name of Issuer: Onkure Therapeutics, Inc. (the Issuer ) (b) Address of Issuers Principal Executive Offices: 6707 Winchester Circle, Suite 400 Boulder, CO 80301 Item2. Filing Person (a)(c) Name of Persons Filing; Address; Citizenship: (i) Acorn Bioventures, L.P., a Delaware limited partnership (Acorn); (ii) Acorn Capital Advisors GP, LLC, a Delaware limited liability company (Acorn GP). Acorn GP is the general partner of Acorn. (iii) Anders Hove, a citizen of the United States of America. Mr. Hove is the manager of Acorn GP. The address of the principal business office of the Reporting Persons is 420 Lexington Avenue, Suite 2626, New York, NY 10170. (d) Title of Class of Securities: Class A Common Stock, par value $0.0001 per share ( Class A Common Stock ) (e) CUSIP Number: 68277Q105 Item3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under Section 15 of the Act; (b) Bank as defined in Section 3(a)(6) of the Act; (c) Insurance company as defined in Section 3(a)(19) of the Act; (d) Investment company registered under Section 8 of the Investment Company Act of 1940; (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) A non-U.S. institution in accordance with Rule 240.13d-

View Full Filing

View this SC 13G filing on SEC EDGAR